Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
Plos One
|
March 24, 2015
High salt intake damages the heart through activation of cardiac (pro) renin receptors even at an early stage of hypertension
Yuka Hayakawa, Takuma Aoyama, Chiharu Yokoyama, et al.
Journal of Gastroenterology and Hepatology
|
May 19, 2022
Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease
Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 10, 2020
Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis
Nobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Journal of Medical Virology
|
September 5, 2020
Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis C
Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology
|
May 31, 2021
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients
Shun Kaneko, Masayuki Kurosaki, Kento Inada, et al.
Journal of Viral Hepatitis
|
January 23, 2021
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment
Sakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Plos One
|
February 23, 2022
The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy
Kenta Takaura, Masayuki Kurosaki, Kento Inada, et al.
Alimentary Pharmacology & Therapeutics
|
December 20, 2021
Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality
Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
September 29, 2021
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
Kento Inada, Shun Kaneko, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology
|
June 21, 2021
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease
Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
Plos One
|
March 24, 2015
High salt intake damages the heart through activation of cardiac (pro) renin receptors even at an early stage of hypertension
Yuka Hayakawa, Takuma Aoyama, Chiharu Yokoyama, et al.
Journal of Gastroenterology and Hepatology
|
May 19, 2022
Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease
Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
June 10, 2020
Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis
Nobuharu Tamaki, Masayuki Kurosaki, Mayu Higuchi, et al.
Journal of Medical Virology
|
September 5, 2020
Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis C
Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology
|
May 31, 2021
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients
Shun Kaneko, Masayuki Kurosaki, Kento Inada, et al.
Journal of Viral Hepatitis
|
January 23, 2021
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment
Sakura Kirino, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Plos One
|
February 23, 2022
The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy
Kenta Takaura, Masayuki Kurosaki, Kento Inada, et al.
Alimentary Pharmacology & Therapeutics
|
December 20, 2021
Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality
Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
September 29, 2021
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
Kento Inada, Shun Kaneko, Masayuki Kurosaki, et al.
Journal of Gastroenterology and Hepatology
|
June 21, 2021
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease
Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, et al.
Page
of 5